Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
10:00am, Monday, 07'th Apr 2025
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why Hims & Hers Health Stock Couldn't Beat the Market Today
06:18pm, Wednesday, 02'nd Apr 2025
Hims & Hers Health (HIMS 0.37%) stock labored mightily on Wednesday, but in the end, it couldn't top the benchmark S&P 500 index. Investor excitement about news of a fresh product launch the previous
3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes
03:00pm, Wednesday, 02'nd Apr 2025
In 2025, companies like MASI, BSX and HIMS are expected to overcome challenges and sustain strong growth and market leadership.
Hims & Hers shares rise as company adds Eli Lilly's Zepbound
07:44pm, Tuesday, 01'st Apr 2025
CNBC's Brandon Gomez joins 'Closing Bell' to discuss Hims & Hers shares rising as company adds new weight-loss medications to platform.
Why Hims & Hers Health Stock Soared Tuesday
04:15pm, Tuesday, 01'st Apr 2025
Shares of Hims & Hers Health (HIMS 5.01%) surged on Tuesday, closing the session up 5.25% after having been up by as much as 14% earlier. That jump came as the S&P 500 and Nasdaq Composite showed more
Hims & Hers shares rise as company adds new weight-loss medications to platform
03:21pm, Tuesday, 01'st Apr 2025
Hims & Hers Health is adding Eli Lilly's weight loss medication Zepbound and diabetes drug Mounjaro, as well as the generic injection liraglutide, to its platform. The company's GLP-1 offerings have e
Hims Stock Rockets After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound
02:30pm, Tuesday, 01'st Apr 2025
Hims stock surged Tuesday after the compounding pharmacy said it would sell Eli Lilly's branded weight-loss drug on its telehealth platform. The post Hims Stock Rockets After Inking Deal To Sell Eli L
Hims & Hers to sell Lilly's Zepbound on its telehealth platform
01:39pm, Tuesday, 01'st Apr 2025
Telehealth firm Hims & Hers Health said on Monday it plans to sell Eli Lilly's weight-loss drug Zepbound on its platform.
Hims & Hers Health, Inc. (HIMS) Surpasses Market Returns: Some Facts Worth Knowing
06:51pm, Monday, 31'st Mar 2025
The latest trading day saw Hims & Hers Health, Inc. (HIMS) settling at $29.55, representing a +1.41% change from its previous close.
Is Hims & Hers Stock Too Cheap to Pass Up?
08:15am, Saturday, 29'th Mar 2025
Hims & Hers (HIMS -8.84%) has seen incredibly high growth, but the market is skeptical that will continue. In this video, Travis Hoium shows just how cheap the stock is today.
Is Hims & Hers Health Stock a Smart Buy After Plunging More Than 50%?
04:55am, Friday, 28'th Mar 2025
What goes up can come down. Investors who jumped on the Hims & Hers Health (HIMS -4.12%) bandwagon have experienced this pain first-hand.
Here's why Hims & Hers stock price has crashed: buy the dip?
04:13am, Thursday, 27'th Mar 2025
Hims & Hers stock price has imploded this year, erasing some of the gains made in 2024 when it became one of the top-performing companies in the US. HIMS has crashed to $33.35, down by over 54% from i
Hims & Hers Health: Reaching Escape Velocity Goes Unnoticed By The Market
09:15am, Wednesday, 26'th Mar 2025
I think Hims & Hers Health has achieved "escape velocity", with a 95%+ increase year-over-year in Q4 2024 and expected 56%-63% growth in 2025, net of GLP-1 issues. The market overreacted to HIMS' stoc
Hims & Hers Health, Inc. (HIMS) Stock Declines While Market Improves: Some Information for Investors
06:50pm, Tuesday, 25'th Mar 2025
Hims & Hers Health, Inc. (HIMS) reachead $37.04 at the closing of the latest trading day, reflecting a -0.99% change compared to its last close.
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Tuesday, 25'th Mar 2025
Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
